Epigenetic Drug Effective against Bladder Cancer in Mice
A new mouse study by researchers at Northwestern Medicine offers hope as it demonstrates an epigenetics drug currently being used for blood cancers and rare sarcomas may halt the growth of bladder cancer by activating the immune system.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed